Literature DB >> 12548202

High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Donna Day Baird1, David B Dunson, Michael C Hill, Deborah Cousins, Joel M Schectman.   

Abstract

OBJECTIVE: Uterine leiomyoma, or fibroid tumors, are the leading indication for hysterectomy in the United States, but the proportion of women in whom fibroid tumors develop is not known. This study screened for fibroid tumors, independently of clinical symptoms, to estimate the age-specific proportion of black and white women in whom fibroid tumors develop. STUDY
DESIGN: Randomly selected members of an urban health plan who were 35 to 49 years old participated (n = 1364 women). Medical records and self-report were used to assess fibroid status for those women who were no longer menstruating (most of whom had had hysterectomies). Premenopausal women were screened by ultrasonography. We estimated the age-specific cumulative incidence of fibroid tumors for black and white women.
RESULTS: Thirty-five percent of premenopausal women had a previous diagnosis of fibroid tumors. Fifty-one percent of the premenopausal women who had no previous diagnosis had ultrasound evidence of fibroid tumors. The estimated cumulative incidence of tumors by age 50 was >80% for black women and nearly 70% for white women. The difference between the age-specific cumulative incidence curves for black and white women was highly significant (odds ratio, 2.9; 95% CI, 2.5-3.4; P <.001).
CONCLUSION: The results of this study suggest that most black and white women in the United States develop uterine fibroid tumors before menopause and that uterine fibroid tumors develop in black women at earlier ages than in white women.

Entities:  

Mesh:

Year:  2003        PMID: 12548202     DOI: 10.1067/mob.2003.99

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  549 in total

1.  Uterine artery embolisation.

Authors:  Rajeev Bhardwaj
Journal:  Indian Heart J       Date:  2012 May-Jun

2.  Pregnancy-related fibroid reduction.

Authors:  Shannon K Laughlin; Amy H Herring; David A Savitz; Andrew F Olshan; Julia R Fielding; Katherine E Hartmann; Donna D Baird
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

3.  Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata.

Authors:  Lauren A Wise; Rose G Radin; Julie R Palmer; Shiriki K Kumanyika; Deborah A Boggs; Lynn Rosenberg
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

4.  Self-report versus ultrasound measurement of uterine fibroid status.

Authors:  Sharon L Myers; Donna Day Baird; Andrew F Olshan; Amy H Herring; Jane C Schroeder; Leena A Nylander-French; Katherine E Hartmann
Journal:  J Womens Health (Larchmt)       Date:  2011-11-01       Impact factor: 2.681

5.  Hysteroscopic morcellation for treating intrauterine pathology.

Authors:  Sarah Cohen; James A Greenberg
Journal:  Rev Obstet Gynecol       Date:  2011

6.  Contemporary management of fibroids in pregnancy.

Authors:  Hee Joong Lee; Errol R Norwitz; Julia Shaw
Journal:  Rev Obstet Gynecol       Date:  2010

7.  Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium.

Authors:  Erica E Marsh; Zhihong Lin; Ping Yin; Magdy Milad; Debabrata Chakravarti; Serdar E Bulun
Journal:  Fertil Steril       Date:  2007-09-04       Impact factor: 7.329

8.  Association between serum 25-hydroxyvitamin D and ovarian reserve in premenopausal women.

Authors:  Anne Marie Z Jukic; Anne Z Steiner; Donna D Baird
Journal:  Menopause       Date:  2015-03       Impact factor: 2.953

Review 9.  Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC).

Authors:  Mei Hua Wong; Chuen Seng Tan; Soo Chin Lee; Yvonne Yong; Aik Seng Ooi; Joanne Ngeow; Min Han Tan
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

10.  Air pollution and risk of uterine leiomyomata.

Authors:  Shruthi Mahalingaiah; Jaime E Hart; Francine Laden; Kathryn L Terry; Renée Boynton-Jarrett; Ann Aschengrau; Stacey A Missmer
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.